| Mast Cell Leukemia studied in …STUDIED_INderived25 of 25show fewer |
|---|
| → studied in | NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996875Phase 2 · recruiting (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03580655Phase 2 · completed (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219266no longer available Managed Access Programs for PKC412, Midostaurin · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02561988Phase 1 · completed (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214666Phase 1/Phase 2 · terminated GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04695431completed Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807598Phase 2 · completed Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00233454Phase 2 · completed Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415608Phase 2 · terminated Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898079completed Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00186628Phase 2 · completed Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118352Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02380222completed Patient-Reported Outcome Questionnaire for Systemic Mastocytosis · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387426Phase 2 · terminated Sunitinib in Treating Patients With Idiopathic Myelofibrosis · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231919Phase 1 · completed MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 25 trials mapped (4 active) | — | — | Mast Cell Leukemia | 1 | Observed | clinicaltrials | graph → |